Cochliobolus Sativus - NDC Database
8 records found
Page:
0268-0878 Jan 01, 1965
Cochliobolus Sativus 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-0879 Jan 01, 1965
Cochliobolus Sativus 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-0880 Jan 01, 1965
Cochliobolus Sativus 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-0881 Jan 01, 1965
Cochliobolus Sativus .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-0882 Jan 01, 1965
Cochliobolus Sativus 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-0883 Jan 01, 1965
Cochliobolus Sativus 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-6524 Jan 01, 1965
Cochliobolus Sativus .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
0268-6525 Jan 01, 1965
Cochliobolus Sativus 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
Cochliobolus Sativus 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.